M R Clemens
Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy
Rizzoli R, Eghbali H, Clemens M, Thürlimann B, Degardin M, Steinhauer E, Tubiana-Hulin M, Manegold C, Rückert F, Huss H, Herrmann Z, Pecherstorfer M, Bundred N, Thiébaud D, Body J. Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy. The Journal of clinical endocrinology and metabolism 1999; 84:3545-50.
01.10.1999Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy
01.10.1999The Journal of clinical endocrinology and metabolism 1999; 84:3545-50
Rizzoli R, Eghbali H, Clemens M R, Thürlimann Beat, Degardin M, Steinhauer E U, Tubiana-Hulin M, Manegold C, Rückert F, Huss H J, Herrmann Z, Pecherstorfer M, Bundred N, Thiébaud D, Body J J
Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy
Pecherstorfer M, Huss H, van Eijkeren M, Steinhauer E, Tubiana-Hulin M, Thürlimann B, Clemens M, Degardin M, Manegold C, Body J, Herrmann Z, Thiébaud D. Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996; 14:268-76.
01.01.1996Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy
01.01.1996Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996; 14:268-76
Pecherstorfer M, Huss H J, van Eijkeren M, Steinhauer E U, Tubiana-Hulin M, Thürlimann Beat, Clemens M R, Degardin M, Manegold C, Body J J, Herrmann Z, Thiébaud D